The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
Open Access
- 9 July 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 15 (9) , 2241-2250
Abstract
Obese and overweight children are at risk of developing nonalcoholic fatty liver disease (NAFLD), which can lead to steatohepatitis, cirrhosis, and liver transplantation. Neuropsychiatric conditions affect an increasing proportion of children and often require neuropsychiatric medications (NPMs) that are associated with weight gain and/or drug‐induced liver injury. We sought to evaluate the role that the extended use of NPMs play in pediatric NAFLD. Medical chart review was conducted for 260 patients with NAFLD (NPM = 77, non‐NPM = 183) seen in the Liver Care Center at Children’s Mercy Hospital between 2000 and 2016. Outcome measures included body mass index (BMI) percentile, BMI z‐score, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, and gamma glutamyltransferase, and were collected at diagnosis, 6–18 month follow‐up, and 18–36 months. Controlling for race and metformin, there was a significant increase over time in BMI z‐score (p < 0.01) and total bilirubin (p = 0.03), with only initial decreases in ALT (p < 0.01) and AST (p < 0.01). Except for higher total bilirubin in the non‐NPM group, no main effect of group or interaction effect was found. Similar patterns remained when subjects were analyzed by NPM drug class. Further study is needed to confirm these findings and to evaluate the effects of NPM dose and duration of exposure, by drug class, on pediatric NAFLD outcomes.Keywords
This publication has 28 references indexed in Scilit:
- Overweight in Childhood, Adolescence and Adulthood and Cardiovascular Risk in Later Life: Pooled Analysis of Three British Birth CohortsPLOS ONE, 2013
- A Critical Appraisal of Advances in Pediatric Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2013
- Diagnosis of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJournal of Pediatric Gastroenterology and Nutrition, 2012
- Characteristics of Idiosyncratic Drug‐induced Liver Injury in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2011
- Regulation of Mammalian Autophagy in Physiology and PathophysiologyPhysiological Reviews, 2010
- An Autophagy-Enhancing Drug Promotes Degradation of Mutant α 1 -Antitrypsin Z and Reduces Hepatic FibrosisScience, 2010
- The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 yearsGut, 2009
- A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver diseaseHepatology Research, 2007
- Prevalence of Fatty Liver in Children and AdolescentsPediatrics, 2006
- Heterogeneous Variance: Covariance Structures for Repeated MeasuresJournal of Agricultural, Biological and Environmental Statistics, 1996